VRC MARADC087 00 VP
Alternative Names: cAd3-Marburg vaccine; ChAd3-MARV; VRC-MARADC087-00-VPLatest Information Update: 17 Dec 2025
At a glance
- Originator National Institute of Allergy and Infectious Diseases; ReiThera
- Developer National Institute of Allergy and Infectious Diseases; Sabin Vaccine Institute; The Ethiopia Ministry of Health
- Class Antivirals; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Marburg virus disease